1. Home
  2. LGIH vs PRCT Comparison

LGIH vs PRCT Comparison

Compare LGIH & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

HOLD

Current Price

$42.40

Market Cap

1.3B

ML Signal

HOLD

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

HOLD

Current Price

$19.90

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGIH
PRCT
Founded
2003
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
LGIH
PRCT
Price
$42.40
$19.90
Analyst Decision
Hold
Analyst Count
0
15
Target Price
N/A
★ $22.25
AVG Volume (30 Days)
340.8K
★ 1.3M
Earning Date
11-03-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1.71
EPS
★ 1.25
N/A
Revenue
★ $1,705,504,000.00
$308,054,000.00
Revenue This Year
$6.07
$28.32
Revenue Next Year
$11.62
$20.48
P/E Ratio
$34.07
★ N/A
Revenue Growth
N/A
★ 37.22
52 Week Low
$33.55
$16.67
52 Week High
$66.25
$38.11

Technical Indicators

Market Signals
Indicator
LGIH
PRCT
Relative Strength Index (RSI) 41.64 57.00
Support Level $39.35 $19.87
Resistance Level $51.77 $22.88
Average True Range (ATR) 2.26 1.03
MACD 0.06 0.29
Stochastic Oscillator 42.96 93.10

Price Performance

Historical Comparison
LGIH
PRCT

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company's current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under the LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company has seven operating segments: West, Northwest, Central, Midwest, Florida, Southeast, and Mid-Atlantic. The majority of the revenue is generated from the Central division segment.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: